TITLE

LUNG ALERT: A clinic service offering isoniazid preventive therapy to HIV infected adults reduces the incidence of tuberculosis

AUTHOR(S)
Khan, A. R.
PUB. DATE
October 2005
SOURCE
Thorax;Oct2005, Vol. 60 Issue 10, p809
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article cites a study which reports on isoniazid preventive therapy to HIV infected adults. This study followed 1655 HIV infected male employees of a South African gold mining company for a median duration of 22.1 months. Isoniazid preventive therapy, 300 mg daily, was offered at clinic enrolment to 679 subjects who attended with no evidence of active tuberculosis. A total of 254 TB episodes met the study criteria. Despite the reduction, the incidence rate is still high at 9 per 100 person-years.
ACCESSION #
18598972

 

Related Articles

  • Pregnancy and tuberculosis: to assess tuberculosis cases in pregnancy in a developing region retrospectively and two case reports. Keskin, Nadi; Yilmaz, Sema // Archives of Gynecology & Obstetrics;Nov2008, Vol. 278 Issue 5, p451 

    To assess TB cases during pregnancy in a developing region retrospectively and to present two case reports. Since TB cases activated by HIV infection during pregnancy are well reported in the literature, we aimed to investigate the aggressiveness of pulmonary TB among pregnant women and to...

  • Pharmacokinetics of Raltegravir in HIV-Infected Patients on Rifampicin-Based Antitubercular Therapy. Taburet, Anne-Marie; Sauvageon, Hélène; Grinsztejn, Beatriz; Assuied, Alex; Veloso, Valdilea; Pilotto, José Henrique; De Castro, Nathalie; Grondin, Carine; Fagard, Catherine; Molina, Jean-Michel // Clinical Infectious Diseases;10/15/2015, Vol. 61 Issue 8, p1328 

    Background: Rifampicin (RIF) induces UGT1A1, an enzyme involved in raltegravir (RAL) elimination, thereby potentially lowering RAL exposure. We examined the pharmacokinetics of RAL in human immunodeficiency virus (HIV)-infected patients on RIF-based antitubercular therapy in the French National...

  • Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru. Campos, Pablo E.; Suarez, Pedro G.; Sanchez, Jorge; Zavala, David; Arevalo, Jorge; Ticona, Eduardo; Nolan, Charles M.; Hooton, Thomas M.; Holmes, King K. // Emerging Infectious Diseases;Dec2003, Vol. 9 Issue 12, p1571 

    During 1999 to 2000, we identified HIV-infected persons with new episodes of tuberculosis (TB) at 10 hospitals in Lima, Peru, and a random sample of other Lima residents with TB. Multidrug-resistant (MDR)-TB was documented in 35 (43%) of 81 HIV-positive patients and 38 (3.9%) of 965 patients...

  • Combining TB and HIV treatment to save lives.  // WHO Drug Information;2004, Vol. 18 Issue 4, p293 

    Reports on the combination of TB and HIV interventions in saving the lives of HIV infected people. Significance of joint TB and HIV treatment; Effectiveness of the combined TB and HIV interventions; Prognosis of people given with combined TB and HIV treatment that people with single treatment only.

  • Testosterone treatment of clinical hypogonadism in patients with HIV/AIDS. Rabkin, Judith G; Rabkin, Richard; Wagner, Glenn J; Rabkin, J G; Rabkin, R; Wagner, G J // International Journal of STD & AIDS;Sep1997, Vol. 8 Issue 9, p537 

    The use of testosterone to treat clinical symptoms of hypogonadism and wasting among patients with HIV/AIDS is a relatively new area of inquiry and clinical application. Outcome measures have included changes in mood, libido, energy, weight and muscle mass. The purpose of this review is to...

  • ECHO: Options for HAART may be limited.  // Sexually Transmitted Infections;Aug2005, Vol. 81 Issue 4, p337 

    The article reports that a small, but growing, group of patients with HIV in Great Britain faces the prospect of running out of treatment options if new antiretroviral drugs do not become available soon. These drugs will need to have low toxicity and not be subject to cross-resistance to...

  • U.S. halts international study on drug-conserving AIDS therapy.  // Gay & Lesbian Times;1/26/2006, Issue 944, p26 

    The article reports on the halt of a major international study of a drug-discovering AIDS therapy because patients are trying the on-again and off-again strategy in the U.S. The study enrolled HIV patients in different countries. The researchers have found that HIV patients only took medicine...

  • Consequences of HIV testing without consent. Obi, Samuel N.; Ifebunandu, Ngozi A. // International Journal of STD & AIDS;Feb2006, Vol. 17 Issue 2, p93 

    The objective of this study is to explore the HIV-infected individuals' experience with HIV testing, counselling, disclosure of diagnosis and subsequent life events following diagnosis. The method used is a questionnaire survey of 340 consecutive HIV-positive victims, seen in two health...

  • Antiretroviral misuse in Mumbai, India. Chinai, Rupa // Bulletin of the World Health Organization;2003, Vol. 81 Issue 2, p153 

    Many patients who have tested HIV-positive in Mumbai, Maharashtra in India are consuming antiretrovirals (ARVs) in fits and starts because of their unstable financial circumstances. According to a senior doctor, patients are being directly approached by medical representatives of drugs firms and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics